Project description
Safer gloves for medical personnel
Medical gloves are examples of personal protective equipment used to guard the wearer from the spread of infection or illness. Even though advanced medical equipment is in use, fatal needle-stick accidents are not rare. The infection of medical personnel has significant impacts on their health and causes huge economic losses for hospitals. Surgeons and nurses wear two gloves on top of each other for major protection. The replacement of double gloving in the surgical sector follows the EU directive on the prevention of workers’ injuries due to medical sharps. The EU-funded SafeGlov project proposes an innovative double gloving based on microparticles and multilayers entirely produced by natural raw materials. The product offers high protection and enhanced capabilities to medical personnel.
Objective
Despite high-tech medical equipment the recurrent incidence of fatal needlestick injuries and persistent thread of subsequent infections of medical staff in many clinical applications is a big challenge in today’s modern society. Many surgeons and nurses try to protect themselves from infection risks by wearing two gloves on top of each other. In addition to the high consumption of material precarious working conditions with a permanent thread of serious diseases (HIV, hepatitis C) are drastic consequences for humans constantly exposed to potentially infectious liquids. Also the economic consequences are huge, as follow-up costs amount up to USD 1,691 per needlestick injury (and additional treatment, litigation, compensation costs) for hospitals and society. The project goal of replacing double gloving in surgical fields is fully in line with EU directive 2010/32/EU implemented to prevent workers' injuries caused by all medical sharps (including needlesticks).
Within the SME II project, Smarterials Technology GmbH (ST) introduces a ground-breaking double gloving substitute innovation based on micro-particles, multi-layers and the use of natural raw materials (TRL 6-7) to the European (and global) market. The USPs of high protection, superior tactility and dexterity, less energy and material consumption at low cost will change the rules of the surgical gloves market. During the project production processes at manufacturers need to be adapted, the technology to be demonstrated in core applications (in particular surgery) and detected customers needs to be met in order to prepare the market entry and make this technology the new protection standard in healthcare. This ever-increasing sector is a high-volume market worth more than € 1,4 billion. The SME II project is a major part of ST´s strategy and will lead to significant increase in turnover far beyond € 100 million and to a more environmentally friendly, protected and healthier society in Europe.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciencesclinical medicinesurgery
- medical and health scienceshealth sciencesinfectious diseasesRNA virusesHIV
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Programme(s)
Call for proposal
(opens in new window) H2020-EIC-SMEInst-2018-2020
See other projects for this callSub call
H2020-SMEInst-2018-2020-2
Funding Scheme
SME-2 - SME instrument phase 2Coordinator
12489 Berlin
Germany
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.